EUVIMEDEUVIMED entdecken
EditorialKommentar

Ticagrelor-Induced Dyspnea

Gwangsil Kim, Christopher P Cannon

JACC: Cardiovascular Interventions · 2023

DOI: 10.1016/j.jcin.2023.09.009 ↗

Kurz gefasst

Editorial in der Zeitschrift JACC: Cardiovascular Interventions, 2023. Verfasst von Gwangsil Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea; CPC Clinical Resea…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Acute Coronary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsAcute Coronary SyndromeHumansTicagrelorTreatment OutcomePurinergic P2Y Receptor AntagonistsDyspnea

Stichwörter der Autor:innen

clinical outcomedrug-discontinuationdyspneaticagrelor

Substanzen

TicagrelorPlatelet Aggregation InhibitorsPurinergic P2Y Receptor Antagonists

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea; CPC Clinical Research, Aurora, Colorado, USA.
  • CPC Clinical Research, Aurora, Colorado, USA; Cardiovascular Division, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: cpcannon@bwh.harvard.edu.

Zitieren

APA

Kim, G., & Cannon, C. P. (2023). Ticagrelor-Induced Dyspnea. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2023.09.009

Vancouver

Kim G, Cannon CP. Ticagrelor-Induced Dyspnea. JACC: Cardiovascular Interventions. 2023. doi:10.1016/j.jcin.2023.09.009

BibTeX
@article{Kim2023,
  author = {Kim, Gwangsil and Cannon, Christopher P},
  title = {Ticagrelor-Induced Dyspnea},
  journal = {JACC: Cardiovascular Interventions},
  year = {2023},
  doi = {10.1016/j.jcin.2023.09.009}
}
Kostenlos starten →